Thalassemia severity study for children and teens
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study looks at how severe thalassemia is in children and teens. It may help doctors understand the condition better and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 months and 18 years old.
- You have been diagnosed with thalassemia.
- You have not been diagnosed with any other blood disorder that is not thalassemia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the physical, emotional, and financial challenges faced by children and teens with thalassemia in Sohag, Egypt. Participation involves regular follow-up at a specific clinic and answering questions about your experiences, which may help improve care.
This study looks at how blood transfusions for thalassemia may affect the reproductive system (gonads) in teenagers. It aims to find out if there are any issues so they can be managed early.
This trial tests a new gene therapy (BD211) for children and teens with severe beta-thalassemia who need regular blood transfusions. The treatment uses your own blood stem cells, modified with a working gene, to help your body make healthy red blood cells and reduce the need for transfusions.
This study tests an experimental gene therapy called YOLT-204 for people with sickle cell disease or thalassemia. It aims to see if the treatment is safe and can help reduce symptoms, and participants will be followed long-term.
This study looks at how blood transfusions and thalassemia affect body composition (like muscle and fat) in children. It may help doctors understand and manage growth and nutrition better.
This study looks at what affects growth in children with beta-thalassemia major. It aims to find ways to help children grow better and have a healthier life.
Hear when a new Thalassaemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.